Background: Controlling hyperlipidemia and hypertension could cease mortality among hemodialysis patients. Controversies have arisen regarding the effects of vitamin E and omega-3 fatty acid on these parameters. We have designed the present study to determine the effects of supplementary vitamin E, omega-3 fatty acids and combined regimen on serum lipids and hypertension in hemodialysis patients. This was done in National Nutrition Institute in 1998-99.Materials and methods: It was a double-blinded sequential clinical trial. The study population included 36 hemodialysis patients with hyperlipidemia (triglyceride 2³200mg/dl or cholesterol³240mg/dl). Subjects were matched according to the age, sex, body mass index, cholesterol, and triglyceride. Then, they have been randomly allocated to 4 groups of control, vitamin E, omega-3 fatty acid, and vitamin E + omega-3 fatty acid. For 10 weeks, the candidates have received the following regimen; "Vitamin E" group: 300mg/d alphatocopherol acetate (three 100mg tablets), "Omega-3 fatty acid" group: 2 grid icosapentaenoic acid (two 1gr oil capsules), "Vitamin E + omega-3 fatty acid" group: 300mg/d alphatocopherol acetate + 2 grid icosapentaenoic acid, and "Control" group: placebo. Fasting blood samples were collected in the beginning and at the 5th and 10th week of study. Then, total cholesterol, triglyceride, LDL, and HDL were determined enzymatically and vitamin: E was measured through HPLC method. Blood pressure was measured one hour after hemodialysls. Meanwhile, dietary pattern was assessed by means of a 24-hour dietary recall questionnaire and anthropometric measurements were also recorded at the aforementioned times.Results: We have found no significant alteration in body mass index and dietary pattern during the study. Basic serum vitamin E levels in control, vitamin E, omega-3 fatty acid, and vitamin E + omega-3 fatty acid groups were 77.88±16.16, 80.15±30.86, 83.18±25.92, and 103.14±35.43 mg/ml, respectively. Significant increase was reported after 5 and 10 weeks of supplementation in "Vitamin E" and "Vitamin E + omega-3 fatty acid" groups. (p<0.001) Meanwhile, LDL level was reported 84.6±25.3, 110.7±41.1, 117.6±46.6, and 113.3±50.9 mg/ml, respectively, at the beginning of the study. The only significant reduction observed after 10 weeks in the omega-3 fatty acid (p<0.05). The other changed in other lipidemic parameters and hypertension was non-significant.Conclusion: Since supplementary omega-3 fatty acid resulted in LDL cholesterol reduction, it is highly recommended according to the individual's requirement.